FHS029i-sh1673B
Application to, and approval by, the Framingham Heart Study is necessary to receive these cell lines.An additional clone (FHS030i-sh1673F) is available from WiCell.
The donor this cell line is derived from is part of the Framingham Heart Study (FHS) Offspring, Exam 9 or Omni I, Exam 4 Cohort. Inclusion in the Framingham Heart Study is population rather than diagnosis based, and therefore no information on health status is listed publicly. All phenotypic and genotypic data on Framingham subjects is available at dbGaP (see link below), and can be reviewed with appropriate permissions. Full medical history is available following application to, and approval from, the Framingham Heart Study.
| Cell Type | Human iPS |
| Sex | Female |
| Age at Collection | 61-70 Years |
| Ethnicity | Caucasian |
| Ethnicity Information | Self-reported |
| Genetically Related Cell Lines | |
| Reprogramming Method | Non-integrating (Sendai: Oct3/4, Sox2, Klf4, cMyc) |
| Tissue Origin | Peripheral Blood Mononuclear Cell |
| Provider | Harvard Stem Cell Institute - Dr. Chad Cowan |
| dbGaP Data | |
| hPSCReg ID | |
| NIH Approval | |
| Pub Med Abstract | |
| Collection(s) | NHLBI Next Gen - Framingham Heart Study Collection (Dr. Chad Cowan, Harvard Stem Cell Institute) |
Current Lot Information
| Lot Number | Culture Platform | Lot Description | Passage Number | Banked By | Protocol | Product Information & Testing |
|---|---|---|---|---|---|---|
| DB67103 | mTeSR1/Matrigel | 25 | Provider | WiCell Feeder Independent Pluripotent Stem Cell Protocol |
